Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease
- PMID: 2041598
- DOI: 10.1212/wnl.41.5_suppl_2.77
Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease
Abstract
Olfactory dysfunction is among the first signs of Alzheimer's disease (AD), idiopathic Parkinson's disease (PD), and the parkinsonism-dementia complex (PDC) of Guam. We have recently demonstrated that the odor identification and detection deficits of patients with PD are equivalent to those of patients with mild AD when subtle differences in cognitive function are statistically controlled for by analysis of covariance. In contrast, patients with progressive supranuclear palsy (PSP) and patients with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism evidence olfactory function much more similar to that of normal controls. In the present study, we administered the University of Pennsylvania Smell Identification Test and the Picture Identification Test to 24 patients with early signs of the PDC of Guam and statistically compared their test scores to those of 24 early-stage AD and 24 early-stage PD patients of similar age and gender from the United States mainland. Although the PDC group evidenced slightly more difficulty in identifying pictures than did the other 2 groups, the odor identification deficit associated with this disorder was of the same magnitude as that observed in AD and PD, suggesting that olfactory testing cannot be used to distinguish among these 3 diseases and that the olfactory dysfunction of these disorders may reflect a common neurologic substrate.
Similar articles
-
Olfactory dysfunction in three neurodegenerative diseases.Geriatrics. 1991 Aug;46 Suppl 1:47-51. Geriatrics. 1991. PMID: 1894145
-
Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia.Neurology. 1998 Dec;51(6):1672-7. doi: 10.1212/wnl.51.6.1672. Neurology. 1998. PMID: 9855521
-
Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.Neurology. 1993 May;43(5):962-5. doi: 10.1212/wnl.43.5.962. Neurology. 1993. PMID: 8492953
-
Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.Handb Clin Neurol. 2021;182:317-329. doi: 10.1016/B978-0-12-819973-2.00030-7. Handb Clin Neurol. 2021. PMID: 34266602 Review.
-
Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.Parkinsonism Relat Disord. 2002 Oct;9(1):39-54. doi: 10.1016/s1353-8020(02)00043-3. Parkinsonism Relat Disord. 2002. PMID: 12217621 Review.
Cited by
-
Cross-cultural modification of the University of Pennsylvania smell identification test for the Saudi Arabian population: Validation and normative values.Saudi Med J. 2024 Jan;45(1):79-85. doi: 10.15537/smj.2024.45.1.20230422. Saudi Med J. 2024. PMID: 38220245 Free PMC article.
-
Disparity of smell tests in Alzheimer's disease and other neurodegenerative disorders: a systematic review and meta-analysis.Front Aging Neurosci. 2023 Sep 7;15:1249512. doi: 10.3389/fnagi.2023.1249512. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37744388 Free PMC article.
-
Olfactory impairment in Wilson's disease.Brain Behav. 2021 Mar;11(3):e02022. doi: 10.1002/brb3.2022. Epub 2021 Jan 7. Brain Behav. 2021. PMID: 33415839 Free PMC article.
-
Smell dysfunction: a biomarker for COVID-19.Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950. doi: 10.1002/alr.22587. Epub 2020 Jun 18. Int Forum Allergy Rhinol. 2020. PMID: 32301284 Free PMC article.
-
Hyposmia as a Predictive Marker of Parkinson's Disease: A Systematic Review and Meta-Analysis.Biomed Res Int. 2019 May 19;2019:3753786. doi: 10.1155/2019/3753786. eCollection 2019. Biomed Res Int. 2019. PMID: 31236405 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous